Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
ZY

NASDAQ · ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

$1.37

Up+$0.03 (+2.24%)

Updated Nov 5, 2026, 3:42 AM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
94.78M
P/E ratio
0
Dividend yield
0.00%
52-week range
$0.62 – $8.01
Volume
38K
Avg. volume
423.1K

Price performance · ZYBT

ZYBT price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

ZYBT closed at $1.37 after 21 trading sessions, up 18.10% for the selected period.

Last close
$1.37
Period change
+18.10%
Period low
$1.15
Period high
$1.73
Daily close
View OHLC price history
ZYBT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$1.37$1.42$1.29$1.3738K
Nov 3, 2026$1.29$1.42$1.29$1.344.77K
Nov 2, 2026$1.31$1.3794$1.25$1.3313K
Oct 30, 2026$1.17$1.40$1.17$1.30122.94K
Oct 29, 2026$1.41$1.50$1.41$1.4324.84K
Oct 28, 2026$1.45$1.475$1.42$1.4216.76K
Oct 27, 2026$1.41$1.48$1.40$1.4488.99K
Oct 26, 2026$1.47$1.50$1.40$1.42157.49K
Oct 23, 2026$1.43$1.55$1.43$1.5089.27K
Oct 22, 2026$1.47$1.52$1.44$1.4696.78K
Oct 21, 2026$1.43$1.53$1.43$1.4651.01K
Oct 20, 2026$1.45$1.54$1.42$1.4917.56K
Oct 19, 2026$1.43$1.56$1.421$1.4541.58K
Oct 16, 2026$1.50$1.57$1.3837$1.4081.61K
Oct 15, 2026$1.50$1.66$1.48$1.5068.34K
Oct 14, 2026$1.45$1.72$1.4402$1.53257.92K
Oct 13, 2026$1.43$1.75$1.43$1.48430.13K
Oct 12, 2026$1.82$1.849$1.38$1.692.93M
Oct 9, 2026$1.19$2.89$1.1218$1.7330.6M
Oct 8, 2026$1.13$1.1681$1.12$1.149910.57K
Oct 7, 2026$1.09$1.18$1.09$1.1631.74K

Latest ZYBT news

The latest Smart Investors Daily articles mentioning ZYBT.

Stock researchCompany · Overview

ZYBT research

Overview

Company profile and research snapshot.

Company profile

Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 6, 2026

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Jilin, China, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced that on August 5, 2026, the Company received a letter (the “Compliance Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with th

ChartMill · Jul 23, 2026

Thursday's session: top gainers and losers

Wondering how the US markets performed one hour before the close of the markets on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By